Luminal genes (e.g., ESR1, PGR, NAT1, BCL2, SLC39A6) were higher expressed in luminal tumors in both DCIS and IBC compared with tumors of basal-like and HER2-enriched subtypes. This evidence concerns the gene SLC39A6 and inflammatory breast carcinoma.